Patents by Inventor Robert E. Nordquist
Robert E. Nordquist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240117075Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.Type: ApplicationFiled: August 23, 2023Publication date: April 11, 2024Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
-
Patent number: 11773188Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.Type: GrantFiled: August 9, 2021Date of Patent: October 3, 2023Assignee: Immunophotonics, IncInventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
-
Publication number: 20220017647Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.Type: ApplicationFiled: August 9, 2021Publication date: January 20, 2022Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
-
Publication number: 20200339706Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.Type: ApplicationFiled: July 5, 2018Publication date: October 29, 2020Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
-
Publication number: 20190002594Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.Type: ApplicationFiled: July 5, 2018Publication date: January 3, 2019Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
-
Publication number: 20180312611Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.Type: ApplicationFiled: July 5, 2018Publication date: November 1, 2018Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
-
Publication number: 20160220684Abstract: Transdermal compositions including chitosan, glycated chitosan, or a combination thereof are provided for use in treatment methods wherein the compositions are externally applied for relieving pain and inflammation, treating erectile dysfunction, treating acne, causing hair growth, and for veterinary treatment of animals for relieving pain and inflammation.Type: ApplicationFiled: April 19, 2016Publication date: August 4, 2016Inventors: Robert E. Nordquist, James A. Rosacker, Patrick J. Downes
-
Publication number: 20150018748Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.Type: ApplicationFiled: January 17, 2013Publication date: January 15, 2015Applicant: IMMUNOPHOTONICS, INC.Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
-
Patent number: 7160264Abstract: An ophthalmic implant having a body for positioning in a recess created in the sclera, feet for positioning in the anterior chamber, and a neck between the body and the feet for positioning in a scleral opening created between the scleral recess and the anterior chamber. The implant feet extend beyond the implant body and have a curvature approximating the curvature of the anterior chamber. The implant has drainage passageways for draining ocular fluid from the anterior chamber. The passageways are formed in outer surfaces or through the interior of the implant. Interior passageways are formed in surfaces of layers of the implant or by voids in inner layers of the implant. Related methods include creating undercuts that receive outer portions of the implant body and creating a scleral opening that is longer than the implant neck.Type: GrantFiled: December 16, 2003Date of Patent: January 9, 2007Assignee: Medtronic-Xomed, Inc.Inventors: James R. Lisk, Jr., James E. Memmen, Scott M. Hampton, Robert E. Nordquist, Philip Vincent Robledo, Ming-Kok Tai
-
Publication number: 20040260227Abstract: An ophthalmic implant having a body for positioning in a recess created in the sclera, feet for positioning in the anterior chamber, and a neck between the body and the feet for positioning in a scleral opening created between the scleral recess and the anterior chamber. The implant feet extend beyond the implant body and have a curvature approximating the curvature of the anterior chamber. The implant has drainage passageways for draining ocular fluid from the anterior chamber. The passageways are formed in outer surfaces or through the interior of the implant. Interior passageways are formed in surfaces of layers of the implant or by voids in inner layers of the implant. Related methods include creating undercuts that receive outer portions of the implant body and creating a scleral opening that is longer than the implant neck.Type: ApplicationFiled: December 16, 2003Publication date: December 23, 2004Inventors: James R. Lisk, James E. Memmen, Scott M. Hampton, Robert E. Nordquist, Philip Vincent Robledo, Ming-Kok Tai
-
Patent number: 6756363Abstract: Preparations containing glycated chitosan in a physiologically compatible carrier are described. Viscoelastic preparations comprise 1.0-12.0 percent by weight of glycated chitosan in an aqueous solution while lower viscosity solutions possess 0.1-0.5 percent by weight glycated chitosan. The otherwise free amino groups of the chitosan polymer are preferably 30-90% glycated and possess an average molecular weight of between 100,000 and 2,000,000 Daltons, and, most preferably between 100,000 and 1,000,000 Daltons.Type: GrantFiled: November 17, 2000Date of Patent: June 29, 2004Assignee: Wound Healing of Oklahoma, Inc.Inventors: Robert E. Nordquist, Raoul Carubelli
-
Patent number: 6673095Abstract: An apparatus for the delivery of laser light in a therapeutic environment including: a console; an optical waveguide wherein a first end of the waveguide is configured to expose a biological tissue to energy transmitted through the waveguide; a plurality of laser diodes housed within the console such that the light emitted by each of the diodes will illuminate a second end of the optical wave guide; and a power supply for providing electrical power to each laser diode. Preferably each laser diode is configured to produce a unique wavelength of light. The power supply provides an independently controllable output for each laser such that the exposure, both in terms of intensity and duration, to each wavelength of light may be controlled independently of the exposure to each of the other wavelengths of light.Type: GrantFiled: February 12, 2001Date of Patent: January 6, 2004Assignee: Wound Healing of Oklahoma, Inc.Inventor: Robert E. Nordquist
-
Publication number: 20020136729Abstract: The present invention combines physical and immunologic therapies for the treatment of neoplasms by conditioning a targeted neoplasm with an immunoadjuvant (also called immunomodulator or immunopotentiator) and then physically destroying the conditioned neoplasm. A number of physical therapies can be used to achieve the physical destruction of the conditioned tumor mass.Type: ApplicationFiled: November 5, 2001Publication date: September 26, 2002Applicant: Wound Healing of OklahomaInventors: Robert E. Nordquist, Raoul Carubelli, Wei R. Chen
-
Publication number: 20020111610Abstract: An apparatus for the delivery of laser light in a therapeutic environment including: a console; an optical waveguide wherein a first end of the waveguide is conffigured to expose a biological tissue to energy transmitted through the waveguide; a plurality of laser diodes housed within the console such that the light emitted by each of the diodes will illuminate a second end of the optical wave guide; and a power supply for providing electrical power to each laser diode. Preferably each laser diode is configured to produce a unique wavelength of light. The power supply provides an independently controllable output for each laser such that the exposure, both in terms of intensity and duration, to each wavelength of light may be controlled independently of the exposure to each of the other wavelengths of light.Type: ApplicationFiled: February 12, 2001Publication date: August 15, 2002Inventor: Robert E. Nordquist
-
Patent number: 6316007Abstract: The present invention combines physical and immunologic therapies for the treatment of neoplasms by conditioning a targeted neoplasm with an immunoadjuvant (also called immuno-modulator or immunopotentiator) and then physically destroying the conditioned neoplasm. A number of physical therapies can be used to achieve the physical destruction of the conditioned tumor mass.Type: GrantFiled: March 19, 1998Date of Patent: November 13, 2001Assignee: Wound Healing of OklahomaInventors: Robert E. Nordquist, Wei Chen, Raoul Carubelli
-
Patent number: 6290712Abstract: A method for treating a neoplasm, such as a malignant tumor, in humans and other animals, is disclosed. A chromophore and an immunoadjuvant are introduced into the neoplasm. The neoplasm is then lased at an irradiance sufficient to induce neoplastic cellular destruction and to stimulate the self-immunological defense system against neoplastic cellular multiplication.Type: GrantFiled: July 3, 1997Date of Patent: September 18, 2001Assignee: Wound Healing of OklahomaInventors: Robert E. Nordquist, Wei R. Chen, Raoul Carubelli
-
Patent number: 6149671Abstract: A method for treating a neoplasm, such as a malignant tumor, in humans and other animals, is disclosed. A chromophore and an immunoadjuvant are introduced into the neoplasm. The neoplasm is then lased at an irradiance sufficient to induce neoplastic cellular destruction and to stimulate the self-immunological defense system against neoplastic cellular multiplication.Type: GrantFiled: November 7, 1997Date of Patent: November 21, 2000Assignee: Wound Healings of OklahomaInventors: Robert E. Nordquist, Wei R. Chen, Raoul Carubelli
-
Patent number: 6102045Abstract: A method and apparatus for lowering the intraocular pressure of an eye are provided. The apparatus is a filtering implant comprising a cellulosic membrane adapted to extend from the anterior chamber of the eye through an opening in the limbus corneae to a drainage area beneath a scleral flap. In its most preferred embodiment, the cellulosic membrane consists essentially of a homopolymer of glucose units connected in a 1,4'-.beta. linkage. The implant is of a planar, generally rectangular shape. The method involves preparing and implanting the device within the eye such that it extends from the anterior chamber of the eye through an opening in the limbus corneae to a drainage area beneath a scleral flap.Type: GrantFiled: December 24, 1997Date of Patent: August 15, 2000Assignee: Premier Laser Systems, Inc.Inventors: Robert E. Nordquist, Bing Li
-
Patent number: 6099554Abstract: A method for the delivery of laser light for therapeutic purposes, and, more specifically, for the treatment of buried tumors wherein multiple lasers are used to treat a deeply buried tumorous mass. In more particular, multiple lasers in a spatial array are used to simultaneous irradiate a tumor from a multiplicity of different directions. Tumors treated in this way are heated more homogeneously than those treated via conventional single-laser treatments. Additionally, a multiple source laser treatment scheme puts the enclosing normal tissue at lesser risk than it would be exposed to if the treatment were conducted using via a single laser source.Type: GrantFiled: April 1, 1998Date of Patent: August 8, 2000Assignee: Wound Healing of OklahomaInventors: Robert E. Nordquist, Wei R. Chen
-
Patent number: 5953101Abstract: A vision collimator for self-monitoring peripheral vision loss or central visual field limitation. The collimator includes a hand-held collimator housing having a viewing aperture for placement adjacent to the subject's eye. A lens projects an image to the eye, which image is formed by the terminal ends of the blades of an iris diaphragm. The angular size of the image is adjustable by opening or closing the iris diaphragm to obtain a measurement indicative of the peripheral vision loss or the central visual field limitation. A diffuser is positioned behind the iris diaphragm to provide an even back-illumination, and indicia markings indicate the measurement. The device is particularly suitable for home use by persons with glaucoma or macular degeneration.Type: GrantFiled: February 9, 1998Date of Patent: September 14, 1999Assignee: Wound Healing of OklahomaInventor: Robert E. Nordquist